Inventiva ADR (IVA): Next-Year EPS Estimate 51.79%
As of 2026-03-30, Inventiva ADR (IVA) has a next-year EPS growth estimate of 51.79%.
On 2026-03-26, analyst consensus for IVA's next-year EPS growth shifted from 45.63% to 51.79% — a positive change of 6.16 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 51.79%
- EPS growth this year
- N/A
- EPS next quarter (est)
- N/A
- Last price
- $5.72
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-03-30 | 51.79% | N/A | N/A | $5.72 |
| 2026-03-30 | 51.79% | N/A | N/A | $5.48 |
| 2026-03-30 | 51.79% | N/A | N/A | $5.48 |
| 2026-03-29 | 51.79% | N/A | N/A | $5.72 |
| 2026-03-29 | 51.79% | N/A | N/A | $5.72 |
| 2026-03-27 | 51.79% | N/A | N/A | $5.72 |
| 2026-03-26 | 51.79% | N/A | N/A | $6.09 |
| 2026-03-26 | 51.79% | N/A | N/A | $6.09 |
| 2026-03-26 | 51.79% | N/A | N/A | $6.09 |
| 2026-03-25 | 45.63% | N/A | N/A | $6.02 |
| 2026-03-25 | 51.79% | N/A | N/A | $6.02 |
| 2026-03-25 | 51.79% | N/A | N/A | $6.02 |
| 2026-03-24 | 45.63% | N/A | N/A | $6.02 |
| 2026-03-24 | 45.63% | N/A | N/A | $6.02 |
| 2026-03-24 | 45.63% | N/A | N/A | $6.02 |
| 2026-03-23 | 45.63% | N/A | N/A | $6.08 |
| 2026-03-20 | 45.63% | N/A | N/A | $5.78 |
| 2026-03-19 | 45.63% | N/A | N/A | $6.04 |
| 2026-03-18 | 45.63% | N/A | N/A | $5.96 |
| 2026-03-17 | 47.23% | N/A | N/A | $6.16 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Inventiva ADR's next-year EPS growth estimate?▾
As of 2026-03-30, Inventiva ADR (IVA) has a next-year EPS growth estimate of 51.79%, based on analyst consensus.
When was the latest EPS estimate revision for IVA?▾
The most recent revision occurred on 2026-03-26, when analysts adjusted the next-year EPS growth estimate from 45.63% to 51.79%.
What sector and industry does Inventiva ADR belong to?▾
Inventiva ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IVA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Inventiva ADR (IVA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports